Parainfluenza Virus Infection
- PMID: 27486735
- PMCID: PMC7171724
- DOI: 10.1055/s-0036-1584798
Parainfluenza Virus Infection
Abstract
Human parainfluenza viruses (HPIVs) are single-stranded, enveloped RNA viruses of the Paramyoviridaie family. There are four serotypes which cause respiratory illnesses in children and adults. HPIVs bind and replicate in the ciliated epithelial cells of the upper and lower respiratory tract and the extent of the infection correlates with the location involved. Seasonal HPIV epidemics result in a significant burden of disease in children and account for 40% of pediatric hospitalizations for lower respiratory tract illnesses (LRTIs) and 75% of croup cases. Parainfluenza viruses are associated with a wide spectrum of illnesses which include otitis media, pharyngitis, conjunctivitis, croup, tracheobronchitis, and pneumonia. Uncommon respiratory manifestations include apnea, bradycardia, parotitis, and respiratory distress syndrome and rarely disseminated infection. Immunity resulting from disease in childhood is incomplete and reinfection with HPIV accounts for 15% of respiratory illnesses in adults. Severe disease and fatal pneumonia may occur in elderly and immunocompromised adults. HPIV pneumonia in recipients of hematopoietic stem cell transplant (HSCT) is associated with 50% acute mortality and 75% mortality at 6 months. Though sensitive molecular diagnostics are available to rapidly diagnose HPIV infection, effective antiviral therapies are not available. Currently, treatment for HPIV infection is supportive with the exception of croup where the use of corticosteroids has been found to be beneficial. Several novel drugs including DAS181 appear promising in efforts to treat severe disease in immunocompromised patients, and vaccines to decrease the burden of disease in young children are in development.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Figures










Similar articles
-
Human parainfluenza virus types 1-4 in hospitalized children with acute lower respiratory infections in China.J Med Virol. 2016 Dec;88(12):2085-2091. doi: 10.1002/jmv.24580. Epub 2016 May 30. J Med Virol. 2016. PMID: 27197630 Free PMC article.
-
The landscape of extrapulmonary manifestations of human parainfluenza viruses: A systematic narrative review.Microbiol Immunol. 2021 Jan;65(1):1-9. doi: 10.1111/1348-0421.12865. Epub 2020 Dec 31. Microbiol Immunol. 2021. PMID: 33270253 Review.
-
Severe lower respiratory tract infections associated with human parainfluenza viruses 1-3 in children infected and noninfected with HIV type 1.Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):499-505. doi: 10.1007/s10096-002-0754-9. Epub 2002 Jun 29. Eur J Clin Microbiol Infect Dis. 2002. PMID: 12172740
-
Clinical and epidemiological characteristics of human parainfluenza virus infections of children in southern Taiwan.J Microbiol Immunol Infect. 2018 Dec;51(6):749-755. doi: 10.1016/j.jmii.2016.08.017. Epub 2017 Jun 22. J Microbiol Immunol Infect. 2018. PMID: 28757139
-
Parainfluenza viruses.Clin Microbiol Rev. 2003 Apr;16(2):242-64. doi: 10.1128/CMR.16.2.242-264.2003. Clin Microbiol Rev. 2003. PMID: 12692097 Free PMC article. Review.
Cited by
-
Epicatechin analogues may hinder human parainfluenza virus infection by inhibition of hemagglutinin neuraminidase protein and prevention of cellular entry.J Mol Model. 2022 Sep 16;28(10):319. doi: 10.1007/s00894-022-05310-9. J Mol Model. 2022. PMID: 36109366
-
Interactions among acute respiratory viruses in Beijing, Chongqing, Guangzhou, and Shanghai, China, 2009-2019.Influenza Other Respir Viruses. 2023 Nov 12;17(11):e13212. doi: 10.1111/irv.13212. eCollection 2023 Nov. Influenza Other Respir Viruses. 2023. PMID: 37964991 Free PMC article.
-
Epidemiological Study of Respiratory Virus Infections among Hospitalized Children Aged 14 Years and Younger during COVID-19 Pandemic in Wuhan, China, 2018-2022.J Glob Infect Dis. 2023 Nov 30;15(4):149-155. doi: 10.4103/jgid.jgid_138_23. eCollection 2023 Oct-Dec. J Glob Infect Dis. 2023. PMID: 38292693 Free PMC article.
-
Virological Surveillance and Molecular Characterization of Human Parainfluenzavirus Infection in Children with Acute Respiratory Illness: Germany, 2015-2019.Microorganisms. 2021 Jul 14;9(7):1508. doi: 10.3390/microorganisms9071508. Microorganisms. 2021. PMID: 34361941 Free PMC article.
-
Sialic Acids as Receptors for Pathogens.Biomolecules. 2021 Jun 2;11(6):831. doi: 10.3390/biom11060831. Biomolecules. 2021. PMID: 34199560 Free PMC article. Review.
References
-
- Glezen W P, Frank A L, Taber L H, Kasel J A. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis. 1984;150(6):851–857. - PubMed
-
- Glezen W P, Loda F A, Clyde W A Jr. et al.Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr. 1971;78(3):397–406. - PubMed
-
- Denny F W, Murphy T F, Clyde W A Jr, Collier A M, Henderson F W. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983;71(6):871–876. - PubMed
-
- Henrickson K J, Kuhn S M, Savatski L L. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis. 1994;18(5):770–779. - PubMed
-
- Knott A M, Long C E, Hall C B. Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J. 1994;13(4):269–273. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources